Fidelio invests in Alphalyse to support global growth in biologic drug analytics
Fidelio has acquired a majority stake in Alphalyse, a Danish specialist contract research organisation (CRO) focused on liquid-chromatography mass-spectrometry (LC-MS) based analytics.
With a fully validated, scalable platform aligned with the latest regulatory standards, Alphalyse is driving a structural shift in the industry away from ELISA-based methods. In partnership with the founders, Fidelio will support the company’s international expansion and continued growth as a global reference in HCP analysis.
All news and storiesMore news
All news and stories
KEYTO Group establishes home security as a new business vertical
KEYTO Group continues to broaden its home services offering with a new vertical in home security. The first company to be added is the Swedish company Säkra Larm.
Read more →
Audria expands into the UK with Tandem Property
Audria, a tech-driven real estate-services platform, expands into the UK with the addition of Tandem Property. Tandem Property provides property and asset management solutions, and is the fifth company to join Audria, following Newsec, Novier, Sveaviken and Avy.
Read more →Audria strengthens its real estate services offering with the addition of Novier
Audria, which brings together leading real estate services companies with a focus on technology, AI and international growth, strengthens its offering with the addition of Novier.
Read more →